FRANKFURT (Reuters) - Germany's Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients, potentially helping the company's efforts to find drug-industry partners to share further development costs.
from Reuters: Health News https://ift.tt/2IpYF0l
No comments:
Post a Comment